In PRAD, the correlation between DRD1 expression and immune purity was highly significant (correlation = 0.502, p = 4.93e−28), and a similar pattern was noted for immune cells (Fig. 7c). This evidence concerns the gene DRD1 and prostate adenocarcinoma.